USPTO serial 79366850
PYZCHIVA
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Dec 5, 2023
- Examiner
- BARRETT, LEAH N
- Law office
- TMEG LAW OFFICE 106
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with PYZCHIVA?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Charles T. J. Weigell
Charles T. J. Weigell Fross Zelnick Lehrman & Zissu, P.C.151 W. 42nd Street, 17th FloorNew York, NY 10036UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical preparations for the treatment of hematological, autoimmune, inflammatory, respiratory, and transplantation-related diseases and disorders; pharmaceutical preparations for the treatment of generalized myasthenia gravis; pharmaceutical preparations for use in hematology; pharmaceutical preparations for the treatment of autoimmune disorders; pharmaceutical preparations for the treatment of inflammatory diseases; pharmaceutical preparations for treating respiratory diseases; pharmaceutical preparations for the treatment of ulcerative colitis; antidiabetic preparations; human vaccine preparations; pharmaceutical preparations, namely, pharmaceutical preparations, biological formulations, biological preparations, antibody formulations and protein formulations for immunoregulation and for treatment of immunologic disorders, autoimmune diseases, inflammatory diseases, arthritis, cancer, tumor, central nervous system disorders and metabolic diseases; anti-inflammatory preparations; pharmaceutical preparations for the treatment of bone diseases; pharmaceutical preparations for tumor treatment; pharmaceutical preparations for the treatment of diseases of the metabolic system; medicated pharmaceutical preparations for skin treatment; pharmaceutical preparations for psoriasis treatment; pharmaceutical preparations for the treatment of psoriatic arthritis; pharmaceutical preparations for the treatment of Crohn's disease | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Apr 2, 2024 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Mar 7, 2024 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Mar 7, 2024 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Mar 5, 2024 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Dec 5, 2023 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Dec 5, 2023 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Sep 19, 2023 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Sep 19, 2023 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Sep 18, 2023 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Aug 30, 2023 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Aug 30, 2023 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Aug 30, 2023 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Aug 22, 2023 | RFNT | REFUSAL PROCESSED BY IB | — |
| Aug 17, 2023 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Aug 16, 2023 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Aug 15, 2023 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Aug 15, 2023 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 3, 2023 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Aug 3, 2023 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jun 27, 2023 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jun 26, 2023 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 22, 2023 | DOCK | ASSIGNED TO EXAMINER | — |
| Apr 18, 2023 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Apr 12, 2023 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Apr 11, 2023 | LIMI | LIMITATION FROM ORIGINAL APPLICATION ENTERED | — |
| Apr 6, 2023 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |